Correspondingly, Bcl-2 expression was shown to have a beneficial influence on prognosis [46, 47], whereas loss of Bcl-2 was found in 70 % of the aggressive triple-negative BC, and was significantly associated with high proliferation, tumor progression, increased risk of death and recurrence [48]. This evidence concerns the gene BCL2 and neoplasm.